Oncodesign Precision Medicine Reacquires Rights to Its OPM-201 Program From Servier After a Positive Phase I Trial in Healthy Volunteers Yahoo Finance Nawigacja wpisu Oncodesign Precision Medicine Reacquires Rights to Its OPM-201 Program From Servier After a Positive Phase I Trial in Healthy Volunteers – Business Wire Ohio legislature votes to ensure ‘medical free speech’ — but not worm medicine for off-label use: The Wake Up – cleveland.com
